Skip to main content

Table 3 Assessment of exercise tolerance (cardiopulmonary exercise test and six-minute walk test)

From: Pulmonary function and exercise tolerance are related to disease severity in pre-dialytic patients with chronic kidney disease: a cross-sectional study

Variables

Control

Stage 3

Stage 4

Stage 5

P

 

(CG = 9)

(G3 = 10)

(G4 = 10)

(G5 = 9)

 

Cardiopulmonary test

     

RPmax (W/kg)

4.9 ± 1.3

3.7 ± 0.9a

3.0 ± 1.2a

3.2 ± 1.0a

0.007

VO2peak (mL/kg/min)

28.9 ± 7.8

23.3 ± 5.6

21.4 ± 5.2a

20.2 ± 6.9a

0.033

VO2peak (%)

85.4 ± 18.2

75.8 ± 18.3

65.9 ± 16.0a

63.4 ± 16.0a

0.038

VO2AT (mL/kg/min)

20.5 ± 4.1

15.7 ± 3.5a

16.6 ± 3.8a

13.6 ± 3.8a

0.005

VEmax (l/min)

68.2 ± 20.3

60.8 ± 20

49.7 ± 20

56.9 ± 28.9

0.356

HRmax (bpm)

165 ± 14

146 ± 16a

139 ± 23a

129 ± 18a

0.003

HRmax (%)

97.9 ± 34.6

90.0 ± 11.1

82.8 ± 11.5a

79.3 ± 9.9a

0.003

SBPmax (mmHg)

197.5 ± 34.6

202.6 ± 25.8

204.2 ± 35.5

201.7 ± 34.3

0.976

DPBmax (mmHg)

89.7 ± 7.5

97.6 ± 9.2

101.8 ± 18.7

98.8 ± 9.6

0.203

6MWT

     

Distance (m)

627.6 ± 37.8

577.4 ± 66.1

542 ± 57.3a

531.5 ± 84.2a

0.012

% Predicted (%)

90.5 ± 7.6

93.9 ± 7.5

83.4 ± 9.5b

83.0 ± 8.9b

0.017

  1. RPmax Maximum Relative Power, VO 2 peak Peak Oxygen Consumption, VO 2 AT Oxygen Consumption at Anaerobic Threshold, VE Minute Ventalation, HRmax Maximum Heart Rate, SBPmax Maximum Systolic Blood Pressure, DBPmax Maximum Diastolic Blood Pressure.
  2. Post hoc analysis: a = differs from CG at p<0.05; b = differs from G3 at p<0.05.